Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - DEFERRED INCOME TAX
Deferred Income Tax RARE - Ultragenyx Pharmaceutical Inc.
-1.62 M
LAST VALUE
-1.65%
2 YEAR CAGR
60.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR